Hemophilia B gene therapy with a high-specific-activity factor IX … – Pharmacy Today, American Pharmacists Association, pharmacist.com
2 Minute Medicine |
Hemophilia B gene therapy with a high-specific-activity factor IX …
Pharmacy Today, American Pharmacists Association, pharmacist.com Routine—but sometimes ineffective—care for hemophilia B, a bleeding disorder caused by a deficiency or dysfunction of coagulation factor IX, involves administering multiple weekly infusions of exo. Gene Therapy Shows Promise in Factor IX Coagulant Activity for … Recombinant viral vector treatment sustains endogenous factor IX … |
